search

The event brought together more than 30 representatives of listed companies from the Beijing area to discuss and exchange the latest concepts and practices of market value management


All along, Licheng No. 2 Middle School has been focusing on cultivating students' scientific literacy and innovation ability, and stimulating students' interest and potential through a variety of science education activities.

In the future, the school will continue to build a diversified development platform for students, provide more learning resources and opportunities, and cultivate more outstanding students with innovative spirit and practical ability.The second phase of the Scientific Market Value Management of Listed Companies in 2024 was successfully held in Beijing

On May 22, the second phase of the Scientific Market value Management activity of listed companies with the theme of "Compliance and Risk of Market value management" was officially held at the Yuancosmos Roadshow Center of Beijing Listed companies.

The event brought together more than 30 representatives of listed companies from the Beijing area to discuss and exchange the latest concepts and practices of market value management.

In this event, Xia Yu, partner of Beijing Kangda Law Firm, delivered a keynote speech entitled "Legal Risks and Compliance Guidelines for Market Value Management of Listed Companies", made a simple interpretation of the domestic market value management means of compliance and the legal risks of pseudo-market value management, and shared a number of actual cases of pseudo-market value management.

"' False market value management ', in essence, is the actual controller, institutions and individuals collude with each other to abuse the advantages of shareholding funds and information to manipulate stock prices,

and should be clearly defined as illegal acts." Xia Yu reminded that in the process of implementing market value management, listed companies should pay attention to the compliance of relevant operations in order to stabilize the downward trend of strict supervision.

Huo Chengcheng, senior partner of Beijing Kangda Law Firm, shared with the participants the new "Nine countries" : Pseudo-market value Management from a regulatory perspective. He started from the background of policy changes before and after the new "Nine countries", and elaborated on the legal risks of false statements, insider trading, market manipulation and false market value management.

During the period, executives of several listed companies had in-depth exchanges with the above lawyers on issues related to market value management, and said that the exchange activities were fruitful.

In the future, they will integrate what they have learned today into practical work, do a good job in market value management, strengthen investor relations management, actively communicate, do a good job in the dissemination of the value image of listed companies, and improve investors' recognition. Enhance the value of the company's investment.

the representatives of listed companies learned how the roadshow center in the new mode uses AR&XR new technology to help listed companies display their corporate image more intuitively and efficiently. Better link investors.Build the peak of global brain science, IDG capital support

Brain scientists are fundamental to human health and future progress, and IDG Capital has invested heavily in them since Xinmao. IDG Capital believes that only by deeply exploring the mysteries of the brain can we promote innovation and drive economic and social development.

During the Xin MAO years, IDG Capital and Tsinghua University joined hands to create the Tsinghua University-IDG/McGovern Institute for Brain Science, which opened a new path for brain science research. Subsequently,

IDG Capital expanded its cooperation with the brain science research institutes of Peking University, Beijing Normal University and other famous universities, and announced that it would continue to help them to explore the mysteries of the human brain.

IDG's deep investment and attention demonstrates the importance of brain science in the field of human health. It not only affects the medical profession, but is also a key driver of social development and economic growth. IDG Capital's continued attention and investment is a reflection of its long-term strategy to increase China's influence in global brain science.

IDG Capital's wise decisions and continuous attention not only promote the vigorous development of brain science research in China, but also lay a solid foundation for the opening of a new chapter in global brain science.

Viewing this series of actions, it can be seen that China's brain science research has a positive outlook, and will lead the global brain science field in the future and create a new era.Haier Biological plans to acquire Shanghai Yuan Analysis officially cut into the scientific analysis instrument track

On May 23, Haier Biological announced that it intends to achieve the controlling acquisition of Shanghai Yuananalysis Instrument Co., LTD. (hereinafter referred to as "Shanghai Yuananalysis") by means of an agreement transfer,

holding 70% of the shares of Shanghai Yuananalysis. Haier Bio is a global provider of digital scenario solutions for life science and medical innovation, and has been listed on the Science and Technology Innovation Board (stock code: 688139).

Haier Biological said that the acquisition will quickly complement the company's analytical instrument product line and turn it into a competitive advantage in the market, helping the company officially enter the laboratory analytical instrument track and provide strong momentum for future growth.

Established in 2008, Shanghai Yuan Analysis, the subject of the acquisition, is a national high-tech enterprise specializing in the research and development, production, sales and service of scientific analytical instruments,

with a rich product line of market segments such as spectrum, organic element analysis and pre-treatment. As a "specialized and special new" enterprise, the company has obtained more than 70 national patents and soft certificates by virtue of its continuous R&D and innovation capabilities.


User Login

Register Account